ClinicalTrials.gov
ClinicalTrials.gov Menu

Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03799211
Recruitment Status : Completed
First Posted : January 10, 2019
Last Update Posted : January 10, 2019
Sponsor:
Information provided by (Responsible Party):
New York University School of Medicine

Brief Summary:
Migraine patients are oftentimes referred for evidence based behavioral therapies to prevent migraine. Yet, at follow-up visits, they report not seeing the behavioral therapist. This is a pilot feasibility acceptability study to assess whether motivational interviewing (MI) can be implemented in the headache center setting to help improve initiation and adherence to behavioral therapy for migraine. We will also assess patients' reasons for making/not making the appointment.

Condition or disease Intervention/treatment Phase
Migraine Behavioral: Motivational Interviewing Behavioral: Treatment as Usual Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 76 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine
Actual Study Start Date : June 4, 2018
Actual Primary Completion Date : January 1, 2019
Actual Study Completion Date : January 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Migraine

Arm Intervention/treatment
Experimental: Motivational Interviewing Behavioral: Motivational Interviewing
Phone call using motivational interviewing technique

Active Comparator: Usual Care Behavioral: Treatment as Usual
will receive a regular study phone call after three months




Primary Outcome Measures :
  1. Number of patients who make appointment for behavioral therapy [ Time Frame: 3-6 Months ]
    Number of patients who do make an appointment for behavioral therapy


Secondary Outcome Measures :
  1. Number of appointments attended [ Time Frame: 3-6 Months ]
    Of those who initiated behavioral therapy, number of appointments attended



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Migraine diagnosis age 16+
  • English speaking

Exclusion Criteria:

  • Unable to read the questionnaire, no phone number

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03799211


Locations
United States, New York
NYU Langone
New York, New York, United States, 10016
Sponsors and Collaborators
New York University School of Medicine
Investigators
Principal Investigator: Mia Minen, MD NYU Langone

Responsible Party: New York University School of Medicine
ClinicalTrials.gov Identifier: NCT03799211     History of Changes
Other Study ID Numbers: 16-00937
First Posted: January 10, 2019    Key Record Dates
Last Update Posted: January 10, 2019
Last Verified: January 2019

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases